HopeStage
Back to all studies
CompletedNCT02600507

Lumateperone Added to Lithium or Valproate for Bipolar Depression

About this title

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Read the official source — NCT02600507
Medication studyAges 18–75Multiple countriesBipolarity
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Listed locations
Rogers and 70 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 7, 2016
Recruitment status
Completed
Enrollment listed in the registry
529
Sponsor
Intra-Cellular Therapies, Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Bulgaria, Russia, ...
Age range
From 18 Years to 75 Years
Official registry ID
NCT02600507
Official title
Show the full official title

Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Rogers, United States · Cerritos, United States · Costa Mesa, United States

69 more locations
  • Culver City, United States
  • Garden Grove, United States
  • Glendale, United States
  • Lemon Grove, United States
  • Oceanside, United States
  • Pico Rivera, United States
  • Riverside, United States
  • San Diego, United States
  • Santa Rosa, United States
  • Sherman Oaks, United States
  • Temecula, United States
  • Jacksonville, United States
  • Lauderhill, United States
  • Miami, United States
  • Orange City, United States
  • Orlando, United States
  • Atlanta, United States
  • Savannah, United States
  • Chicago, United States
  • Lake Charles, United States
  • Baltimore, United States
  • O'Fallon, United States
  • St Louis, United States
  • Las Vegas, United States
  • Berlin, United States
  • Cherry Hill, United States
  • Toms River, United States
  • Cedarhurst, United States
  • New York, United States
  • Rochester, United States
  • Staten Island, United States
  • Charlotte, United States
  • Cincinnati, United States
  • Dayton, United States
  • Garfield Heights, United States
  • Allentown, United States
  • Philadelphia, United States
  • The Woodlands, United States
  • Everett, United States
  • Burgas, Bulgaria
  • Kardzhali, Bulgaria
  • Lovech, Bulgaria
  • Pleven, Bulgaria
  • Plovdiv, Bulgaria
  • Rousse, Bulgaria
  • Sofia, Bulgaria
  • Varna, Bulgaria
  • Veliko Tarnovo, Bulgaria
  • Vratsa, Bulgaria
  • Moscow, Russia
  • Nizhny Novgorod, Russia
  • Omsk, Russia
  • Saint Petersburg, Russia
  • Samara, Russia
  • Saratov, Russia
  • Tomsk, Russia
  • Belgrade, Serbia
  • Kovin, Serbia
  • Novi Sad, Serbia
  • Šumadija, Serbia
  • Ivano-Frankivsk, Ukraine
  • Kharkiv, Ukraine
  • Kropyvnytskyi, Ukraine
  • Odesa, Ukraine
  • Poltava, Ukraine
  • Smila, Ukraine
  • Vasylkiv, Ukraine
  • Vinnytsia, Ukraine
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Intra-Cellular Therapies, Inc.

Did this study involve medication?

Yes. The study involved medication, including Lumateperone (ITI-007) and Placebo.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies